menu close
www.sermonixpharma.com

Sermonix Pharmaceuticals Stock

Company Profile:

Sermonix Pharmaceuticals is a biotechnology company focused on developing innovative treatments for women's oncology, particularly in the areas of breast and ovarian cancers. Their lead product, lasofoxifene, is being studied for its effectiveness in treating estrogen receptor-positive breast cancer, especially in patients with specific genetic mutations. Sermonix is committed to advancing therapies that address unmet needs in the oncology space.

Sign up for SecondMarket® to view the market and buy or sell Sermonix Pharmaceuticals Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Sermonix Pharmaceuticals Management Team

  • CEO, Chief Medical Officer

    David Portman

  • Board Member

    Thomas Pfisterer

  • Board Member

    Michael Friedman

  • Board Member

    Elizabeth Garner

  • Chief Strategy Officer, Chief Development Officer

    Elizabeth Attias

  • Chief Scientific Officer

    Barry Komm

  • Board Member

    Richard De Schutter

  • Board Member

    Paul Plourde

  • COO

    Miriam Portman

  • Board Member

    Simon Jenkins

  • Board Member

    Anthony Wild

Learn More About Sermonix Pharmaceuticals Stock

Buy Sermonix Pharmaceuticals Stock
01

Sermonix Pharmaceuticals stock does not trade on public stock exchanges. Sermonix Pharmaceuticals stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Sermonix Pharmaceuticals stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Sermonix Pharmaceuticals Stock
02

Sermonix Pharmaceuticals Stock does not trade on public stock exchanges. In order to sell Sermonix Pharmaceuticals shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Sermonix Pharmaceuticals Stock Price
03

Sermonix Pharmaceuticals does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Sermonix Pharmaceuticals share price and other valuable private market data.

Read more about secondary market private company stock prices:

Sermonix Pharmaceuticals Stock Ticker Symbol
04

There is no ticker symbol for Sermonix Pharmaceuticals stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Sermonix Pharmaceuticals Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Sermonix Pharmaceuticals stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Sermonix Pharmaceuticals Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Sermonix Pharmaceuticals stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Sermonix Pharmaceuticals Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Sermonix Pharmaceuticals IPO
08

Sermonix Pharmaceuticals is a private company and has not had an IPO. There is currently no Sermonix Pharmaceuticals IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Sermonix Pharmaceuticals IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Sermonix Pharmaceuticals Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Genomics

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Arsenalbio-Logo

ArsenalBio

Develops programmable cell therapies for cancer patients.

Tessera Therapeutics-Logo

Tessera Therapeutics

Genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.

Source: Nasdaq Private Market Tape D®